Tweets
Best of 2021: Plasmapheresis Indications : TTP, HUS, Cryoglobulinemia, Hyperviscosity, Myasthenia gravis, Goodpastures, Catastrophic APL Syn, Chr inflamm demyelinating polyneuropathy, Removal of drugs/toxins, Alveolar hemorrhage, ANCA vasculitis (questionable)
Dr. John Cush @RheumNow ( View Tweet )
4 years 7 months ago
Best of 2021: ProDERM Study: IVIG in Dermatomyositis--The ProDERM study show that IVIg is safe, effective and superior to placebo in patients with dermatomyositis (DM).
https://t.co/l15ZLBguxH https://t.co/7s23FeUf5g
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 7 months ago
Dr. Jack Cush tells his podcast story - the genesis, keys to success and recommendations on how to get into podcasting - for teaching, practice, fun or influence.
https://t.co/l4emmdM056 https://t.co/uavfamjfI8
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 7 months ago
NEJM Clinical Images - Tongue Necrosis in Giant Cell Arteritis. 74-yoF w/ 3-day hx of HA and tongue swelling/pain, & blindness in the right eye. Tongue was ulcerated, R temporal artery thickened. ESR 42 CRP 169 mg/L. Read rest of story... https://t.co/DDgu0UpZN9 https://t.co/BPlIEmRjg3
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 7 months ago
RESTORE trial: yet another failure for PRP injections for knee #OA. Study of 288 Knee oA over 50 years - knee pain scores of −2.1 vs −1.8 on an 11-point scale (range, 0-10) and no difference between PRP and PBO at 12 moshttps://bit.ly/3pqldWU
Dr. John Cush @RheumNow ( View Tweet )
4 years 7 months ago
Best of 2021: Actemra FDA Approved for Systemic Sclerosis Interstitial Lung Disease
https://t.co/oPKErIgR3J https://t.co/mpWmfVwOsF
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 7 months ago
Patient Medication Preferences in PsA
https://t.co/I1DXCFPNcf https://t.co/cqMGIJwLbA
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 7 months ago
Registration now open for RheumNow Live!
Join us March 19-20 in Irving, TX or virtually!
https://t.co/py6Gp8sPh8
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 7 months ago
Watch: Dual BAFF/APRIL Antagonist for SLE
https://t.co/ktAhM2C0i7
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 7 months ago
ICYMI: AstraZeneca announced that Saphnelo (anifrolumab - Type 1 IFN receptor MAb) was recommended for approval in the EU by CHMP for the treatment of patients with systemic lupus erythematosus https://t.co/Aiem2P4Em0
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 7 months ago
RA Panel: Safety, Multimorbidities, Vaccination and the Weather
https://t.co/0N212LKSzK
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 7 months ago
Watch: Steroids in RA Patients 65 and Older
https://t.co/5cHMfSRSAi
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 7 months ago
